Actively Recruiting
Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center
Led by Hospices Civils de Lyon · Updated on 2024-06-26
162
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Each year in France, over 150,000 people experience strokes, a leading cause of adult disability, along with frequent head injuries causing similar lasting effects. These sudden events severely impact patients and their families physically, emotionally, socially, and financially. Advances in acute stroke treatments have improved survival, but ongoing support for patients returning home remains insufficient despite significant needs. The ARRPAC association is launching the AVanCer program, a specialized day center in Lyon, to enhance autonomy and adaptation for adults with brain injury sequelae and to support their caregivers. The AVanCer program offers therapeutic education, adapted physical activity, social and cognitive remediation, and therapeutic workshops. It aims to complement rehabilitation and recurrence prevention care by providing a space for patients and caregivers to share information and receive listening support. This interventional study evaluates the program's implementation and impact on participants and caregivers using the REAIM framework, monitoring reach, effectiveness, adoption, implementation, and maintenance. Participants will undergo assessments at enrollment, at program end (between 2 and 4 months), and six months later. Researchers will measure goal attainment, quality of life, depression and anxiety levels, autonomy, walking ability, treatment adherence, caregiver burden, and professional adoption of the program. Data collection includes questionnaires and evaluations like the 6-minute walking test and various validated scales. The study will track program sustainability and transferability over about 22 months.
CONDITIONS
Brief Title
Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female of legal age
- Patient selected to start the AVanCer program at the ARRPAC center
- Patient who agrees to participate in the assessment and has signed consent
- Patient able to speak and understand French orally and in writing
- Caregivers of legal age who agree to participate and have signed consent
- Caregivers able to speak and understand French orally and in writing
- Voluntary patients and caregivers who participated in the quantitative part
- Partner professionals referring patients for support
- ARRPAC professionals involved in the day care centre
You will not qualify if you...
- Pregnant women, parturient or breastfeeding mothers
- Persons deprived of liberty by judicial or administrative decision
- Persons under psychiatric care
- Persons admitted to health or social establishments for non-research reasons
- Persons under legal protection measures (guardian, curators)
- Persons not affiliated with a social security scheme or similar
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Between 2 and 4 months
Participants undergo assessment through the AVanCer program using quantitative and qualitative approaches.
1 baseline visit and 1 end-of-program visit (in-person)
Duration - Approximately 6 months after the program ends
Participants are monitored for outcomes and program effects after completing the AVanCer program.
1 follow-up visit (in-person)
Trial Site Locations
Total: 1 location
1
Accueil de jour ARRPAC
Bron, France, 69500
Actively Recruiting
Research Team
J
Julie Haesebaert, MD
A
Anne Termoz
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here